Merck & Co., Inc. (NYSE: MRK) issued the following statement in response to today's communication from the U.S. FDA addressing ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE